Outcomes following cessation of BRAF ± MEK inhibition after achieving complete response in BRAF mutant advanced melanoma

C. Girgis, V. Vanella, A. M. Menzies, A. Guminski, R. F. Kefford, G. V. Long, P. Ascierto, M. S. Carlino

Research output: Contribution to journal › Meeting abstract

Original language	English
Pages (from-to)	41
Number of pages	1
Journal	Asia-Pacific Journal of Clinical Oncology
Volume	12
Issue number	Suppl. 4
Publication status	Published - 2016
Event	Medical Oncology Group of Australia Incorporated Annual Scientific Meeting - Gold Coast, QLD Duration: 3 Aug 2016 → 5 Aug 2016

Cite this

@article{bfd3e49d0fe24dc0bf3ce9759b3dee26,

title = "Outcomes following cessation of BRAF ± MEK inhibition after achieving complete response in BRAF mutant advanced melanoma",

author = "C. Girgis and V. Vanella and Menzies, {A. M.} and A. Guminski and Kefford, {R. F.} and Long, {G. V.} and P. Ascierto and Carlino, {M. S.}",

year = "2016",

language = "English",

volume = "12",

pages = "41",

journal = "Asia-Pacific Journal of Clinical Oncology",

issn = "1743-7555",

publisher = "Wiley-Blackwell, Wiley",

number = "Suppl. 4",

note = "Medical Oncology Group of Australia Incorporated Annual Scientific Meeting ; Conference date: 03-08-2016 Through 05-08-2016",

}

TY - JOUR

T1 - Outcomes following cessation of BRAF ± MEK inhibition after achieving complete response in BRAF mutant advanced melanoma

AU - Girgis, C.

AU - Vanella, V.

AU - Menzies, A. M.

AU - Guminski, A.

AU - Kefford, R. F.

AU - Long, G. V.

AU - Ascierto, P.

AU - Carlino, M. S.

PY - 2016

Y1 - 2016

UR - https://doi.org/10.1111/ajco.12540

M3 - Meeting abstract

C2 - 27435139

SN - 1743-7555

VL - 12

SP - 41

JO - Asia-Pacific Journal of Clinical Oncology

JF - Asia-Pacific Journal of Clinical Oncology

IS - Suppl. 4

T2 - Medical Oncology Group of Australia Incorporated Annual Scientific Meeting

Y2 - 3 August 2016 through 5 August 2016

ER -